Lancaster Synthesis changes hands
Swiss chemicals group Clariant, currently in the throes of a major restructuring exercise, has sold off its UK-based Lancaster Synthesis unit to Johnson Matthey.
Archives for July 12, 2004
Gene mutation contributes to diabetes
A natural mutation of a gene that helps regulate the reactivity of the immune system is a major contributor to type 1 diabetes, researchers have found, writes Wai Lang Chu..
Sun's European RFID centre refocused before launch
Sun Microsystems has delayed the opening of a centre in Scotland that will allow European companies interested in exploring the use of radiofrequency identification technology a base for pilot projects.
Process valve makers link up
Strahman Valves of the US has expanded its product line and increased its presence in Europe with the acquisition of MG Process Valves. Both companies market a range of valves for the pharmaceutical and other process industries.
Excipients overcome virus formulation challenge
Viruses are increasingly being used as delivery vectors in the pharmaceutical industry, for example to deliver genes to cells or DNA sequences that function as vaccines. But formulating them so that the virus' activity is retained presents...